Your browser doesn't support javascript.
loading
Evaluation of care with intravitreal aflibercept treatment for UK patients with diabetic macular oedema: DRAKO study 24-month real-world outcomes.
Sivaprasad, Sobha; Ghanchi, Faruque; Kelly, Simon P; Kotagiri, Ajay; Talks, James; Scanlon, Peter; McGoey, Hellen; Nolan, Andrew; Saddiq, Moneeb; Napier, Jackie.
Affiliation
  • Sivaprasad S; National Institute for Health Research, Moorfields Biomedical Research Centre, London, UK. s.sivaprasad@ucl.ac.uk.
  • Ghanchi F; Bradford Teaching Hospitals NHS Foundation Trust, Bradford, UK.
  • Kelly SP; Bolton Hospital NHS Foundation Trust, Bolton, UK.
  • Kotagiri A; South Tyneside and Sunderland NHS Foundation Trust, Sunderland, UK.
  • Talks J; Newcastle Upon Tyne Hospitals NHS Foundation Trust, Newcastle Upon Tyne, UK.
  • Scanlon P; Gloucestershire Hospitals NHS Foundation Trust, Cheltenham, UK.
  • McGoey H; Bayer Plc, Reading, UK.
  • Nolan A; Ipsen UK Ltd, Slough, UK.
  • Saddiq M; O4 Research Limited, Belfast, UK.
  • Napier J; Bayer Plc, Reading, UK.
Eye (Lond) ; 37(13): 2753-2760, 2023 09.
Article in En | MEDLINE | ID: mdl-36941402
Subject(s)
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Database: MEDLINE Main subject: Macular Edema / Diabetes Mellitus / Diabetic Retinopathy Type of study: Etiology_studies / Incidence_studies / Observational_studies / Risk_factors_studies Limits: Humans Country/Region as subject: Europa Language: En Year: 2023 Type: Article
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Database: MEDLINE Main subject: Macular Edema / Diabetes Mellitus / Diabetic Retinopathy Type of study: Etiology_studies / Incidence_studies / Observational_studies / Risk_factors_studies Limits: Humans Country/Region as subject: Europa Language: En Year: 2023 Type: Article